Mirdametinib

Mirdametinib is a Kinase Inhibitor. The mechanism of action of mirdametinib is as a Mitogen-Activated Protein Kinase Kinase 1 Inhibitor, and Mitogen-Activated Protein Kinase Kinase 2 Inhibitor. It is grouped under the following drug class(es): Kinase inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ezmekly and Gomekli. Its PubChem CID is 9826528.

CAS No 391210-10-9
Molecular Formula C16H14F3IN2O4
Molecular Weight 482.19 g/mol
Synonyms N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide

Frequently Asked Questions